Europe

Spain

Researchers at Barcelona's Vall d'Hebron Institute of Oncology (VHIO) and biotech company Peptomyc have developed a therapeutic protein, Omomyc, that is believed to halt metastatic breast cancer


More lines about Spain, Europe

Visit all Spain lines archive